|
Using the Serum Phosphoproteome of Migraine Patients as a Theragnostic
Biomarkers for neurological disease are lacking. Preliminary data, using an in vitro model of the blood brain barrier has suggested that serum release of tight junction proteins and the associated phosphoproteome may have utility as a biomarker for headache presence (diagnostic), such as migraine, and in therapeutic effect (theragnostic). This invention...
Published: 1/23/2024
|
Inventor(s): Tally Largent-Milnes, Jared Wahl
Keywords(s):
Category(s): Technology Classifications > Healthcare Portfolios
|
